Close

NovaBay Pharma (NBY) Names Lewis Stuart CCO

December 6, 2017 6:53 AM EST Send to a Friend
NovaBay® Pharmaceuticals, Inc. (NYSE: NBY), announces the appointment of Lewis J. Stuart as Chief Commercial Officer. Mr. Stuart joined NovaBay ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login